The Scope of Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH) in Cancer Clinicopathology: A Review

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2021 Mar 6

PMID 33671513

Citations 13

Authors

Maheen Khan

Devanand Sarkar

Affiliations

Soon will be listed here.

Abstract

Since its initial cloning in 2002, a plethora of studies in a vast number of cancer indications, has strongly established AEG-1 as a bona fide oncogene. In all types of cancer cells, overexpression and knockdown studies have demonstrated that AEG-1 performs a seminal role in regulating proliferation, invasion, angiogenesis, metastasis and chemoresistance, the defining cancer hallmarks, by a variety of mechanisms, including protein-protein interactions activating diverse oncogenic pathways, RNA-binding promoting translation and regulation of inflammation, lipid metabolism and tumor microenvironment. These findings have been strongly buttressed by demonstration of increased tumorigenesis in tissue-specific AEG-1 transgenic mouse models, and profound resistance of multiple types of cancer development and progression in total and conditional AEG-1 knockout mouse models. Additionally, clinicopathologic correlations of AEG-1 expression in a diverse array of cancers establishing AEG-1 as an independent biomarker for highly aggressive, chemoresistance metastatic disease with poor prognosis have provided a solid foundation to the mechanistic and mouse model studies. In this review a comprehensive analysis of the current and up-to-date literature is provided to delineate the clinical significance of AEG-1 in cancer highlighting the commonality of the findings and the discrepancies and discussing the implications of these observations.

Citing Articles

LncRNA DDX11-AS1 promotes breast cancer progression by targeting the miR-30c-5p/MTDH axis.

Li Y, Zhou M, Yang L, Liu S, Yang L, Xu B Sci Rep. 2024; 14(1):26745.

PMID: 39501057 PMC: 11538490. DOI: 10.1038/s41598-024-78413-3.

AEG-1 as a Novel Therapeutic Target in Colon Cancer: A Study from Silencing AEG-1 in BALB/c Mice to Large Data Analysis.

Sriramulu S, Malayaperumal S, Banerjee A, Anbalagan M, Kumar M, Radha R Curr Gene Ther. 2024; 24(4):307-320.

PMID: 38783530 DOI: 10.2174/0115665232273077240104045022.

Using the metabolite alterations monitoring the AEG-1 expression level and cell biological behaviour of U251 cell in vitro.

Sheng Y, Yin D, Zeng Q PLoS One. 2023; 18(9):e0291092.

PMID: 37656734 PMC: 10473485. DOI: 10.1371/journal.pone.0291092.

Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis.

Li K, Sun X, Minami K, Tamari K, Ogawa K, Li H Theranostics. 2023; 13(4):1247-1263.

PMID: 36923539 PMC: 10008730. DOI: 10.7150/thno.80294.

Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis.

Ortiz-Soto G, Babilonia-Diaz N, Lacourt-Ventura M, Rivera-Rodriguez D, Quinones-Rodriguez J, Colon-Vargas M Int J Mol Sci. 2023; 24(5).

PMID: 36902125 PMC: 10002532. DOI: 10.3390/ijms24054694.

References

Britt D, Yang D, Yang D, Flanagan D, Callanan H, Lim Y . Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res. 2004; 300(1):134-48. DOI: 10.1016/j.yexcr.2004.06.026. View

Johnson D, Burtness B, Leemans C, Lui V, Bauman J, Grandis J . Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020; 6(1):92. PMC: 7944998. DOI: 10.1038/s41572-020-00224-3. View

Su Z, Kang D, Chen Y, Pekarskaya O, Chao W, Volsky D . Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene. 2002; 21(22):3592-602. DOI: 10.1038/sj.onc.1205445. View

Abdel Ghafar M, Gharib F, Abdel-Salam S, Elkhouly R, Elshora A, Shalaby K . Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer. Mol Biol Rep. 2020; 47(4):2509-2519. DOI: 10.1007/s11033-020-05334-5. View

Hou Y, Yu L, Mi Y, Zhang J, Wang K, Hu L . Association of MTDH immunohistochemical expression with metastasis and prognosis in female reproduction malignancies: a systematic review and meta-analysis. Sci Rep. 2016; 6:38365. PMC: 5137005. DOI: 10.1038/srep38365. View

Sutherland H, Lam Y, Briers S, Lamond A, Bickmore W . 3D3/lyric: a novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Exp Cell Res. 2004; 294(1):94-105. DOI: 10.1016/j.yexcr.2003.11.020. View

Yoo B, Gredler R, Vozhilla N, Su Z, Chen D, Forcier T . Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci U S A. 2009; 106(31):12938-43. PMC: 2722317. DOI: 10.1073/pnas.0901451106. View

Tong L, Wang C, Hu X, Pang B, Yang Z, He Z . Correlated overexpression of metadherin and SND1 in glioma cells. Biol Chem. 2015; 397(1):57-65. DOI: 10.1515/hsz-2015-0174. View

Li P, Feng L, Chen N, Ge X, Lv X, Lu K . Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway. Med Oncol. 2015; 32(2):479. DOI: 10.1007/s12032-014-0479-5. View

10.

Emdad L, Sarkar D, Su Z, Randolph A, Boukerche H, Valerie K . Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 2006; 66(3):1509-16. DOI: 10.1158/0008-5472.CAN-05-3029. View

11.

Erdem H, Oktay M, Yildirim U, Uzunlar A, Kayikci M . Expression of AEG-1 and p53 and their clinicopathological significance in malignant lesions of renal cell carcinomas: a microarray study. Pol J Pathol. 2013; 64(1):28-32. DOI: 10.5114/pjp.2013.34600. View

12.

Meng X, Zhu D, Yang S, Wang X, Xiong Z, Zhang Y . Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein. J Biol Chem. 2011; 287(7):4485-91. PMC: 3281628. DOI: 10.1074/jbc.C111.291518. View

13.

Zhou J, Li J, Wang Z, Yin C, Zhang W . Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival. Asia Pac J Clin Oncol. 2012; 8(3):e42-8. DOI: 10.1111/j.1743-7563.2012.01541.x. View

14.

Brown D, Ruoslahti E . Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell. 2004; 5(4):365-74. DOI: 10.1016/s1535-6108(04)00079-0. View

15.

Liu X, Zhang N, Li X, Moran M, Yuan C, Yan S . Identification of novel variants of metadherin in breast cancer. PLoS One. 2011; 6(3):e17582. PMC: 3050918. DOI: 10.1371/journal.pone.0017582. View

16.

Yao Y, Gu X, Liu H, Wu G, Yuan D, Yang X . Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer. Br J Cancer. 2014; 111(2):355-64. PMC: 4102939. DOI: 10.1038/bjc.2014.267. View

17.

Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D, Fujimura L . Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet. 2011; 56(8):595-601. DOI: 10.1038/jhg.2011.66. View

18.

Zhang F, Yang Q, Meng F, Shi H, Li H, Liang Y . Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma. Mol Carcinog. 2012; 52(8):603-10. DOI: 10.1002/mc.21894. View

19.

Yu C, Chen K, Zheng H, Guo X, Jia W, Li M . Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis. 2009; 30(5):894-901. DOI: 10.1093/carcin/bgp064. View

20.

Rusthoven K, Ballonoff A, Raben D, Chen C . Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer. 2007; 112(2):345-51. DOI: 10.1002/cncr.23183. View